Biophytis Shares Are Trading Higher. The Company Announced the Formation of a New Scientific Advisory Board to Support the Advancement of Its Phase 2 OBA Clinical Study in Obesity.
Biophytis Shares Are Trading Higher. The Company Announced the Formation of a New Scientific Advisory Board to Support the Advancement of Its Phase 2 OBA Clinical Study in Obesity.
Biophytis的股票交易價格走高。該公司宣佈成立一個新的科學顧問委員會，以支持其肥胖症的2期OBA臨床研究的進展。
Biophytis Shares Are Trading Higher. The Company Announced the Formation of a New Scientific Advisory Board to Support the Advancement of Its Phase 2 OBA Clinical Study in Obesity.
Biophytis的股票交易價格走高。該公司宣佈成立一個新的科學顧問委員會，以支持其肥胖症的2期OBA臨床研究的進展。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。